Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 6,865 | 5,427 | 3,919 | 3,543 | 3,570 |
| Cost of Goods | 1,991 | 2,144 | 1,807 | 1,393 | 1,453 |
| Gross Profit | 4,874 | 3,283 | 2,112 | 2,150 | 2,117 |
| Operating Expenses | 5,962 | 3,589 | 4,186 | 4,139 | 3,981 |
| Operating Income | -97 | -162 | -1,267 | -1,596 | -1,412 |
| Other Income | 23 | 9 | -33 | 42 | 31 |
| Pre-tax Income | -74 | -154 | -1,299 | -1,554 | -1,381 |
| Net Income Continuous | -74 | -154 | -1,299 | -1,554 | -1,381 |
| Net Income | $-74 | $-154 | $-1,299 | $-1,554 | $-1,381 |
| EPS Basic Total Ops | 0.00 | N/A | -0.01 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Total Ops | 0.00 | N/A | -0.01 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | -0.02 | -0.02 |
| EBITDA(a) | $-51 | $-106 | $-1,222 | $-1,560 | $-1,371 |